Novo Nordisk chair foresees pressure on pharmaceutical industry

Chair of the Novo Nordisk Board Helge Lund thinks tax payers will be paying a large bill for the Covid-19 crisis. He also expects an additional pressure to fall on the pharmaceutical industry in future years.

Photo: Novo Nordisk Pharmatech/PR

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

WS Audiology plans to list subsidiary

Privately-owned hearing aid company WS Audiology, which grew out of the merger between Widex and Sivantos, plans to list, which handles online sales.

Further reading

Related articles

Latest news

See all jobs